CAR-bearing exosomes could contribute to anti-tumor effects by binding and potentially neutralizing Her2-positive target cells independently of the parental cell, and may also modulate the tumor microenvironment or facilitate intercellular communication. The gene discussed is ERBB2; the disease is neoplasm.